Vaccines and Related Biological Products Advisory Committee
Executive Summary
Will meet Jan. 28-29 to address influenza vaccine formulation for the 1991-92 flu season and review the Intramural Scientific Program. On Jan. 29, the committee will discuss pertussis vaccine and the National Vaccine Program's activities. The meeting begins at 8:00 a.m. in conference room D of FDA's Parklawn building.